Morgan Simmons
Women's Health · Monroe, LANPI 1174616080
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $220 and has fallen 75.4% since, to $54 in 2025.
Across 34 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$144
- Takeda Pharmaceuticals U.S.A., Inc.$132
- Tris Pharma Inc$65
- Evofem Biosciences, Inc.$48
- Astellas Pharma US Inc$44
- Mayne Pharma Commercial LLC$35
- plus $157 from 8 others
What the payments were for
- Food & beverage$625100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 5 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $132 |
| Tris Pharma Inc | 4 | $65 |
| Evofem Biosciences, Inc. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $44 |
| Mayne Pharma Commercial LLC | 3 | $35 |
| Almirall LLC | 2 | $34 |
| Mycovia Pharmaceuticals, Inc. | 1 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| AbbVie | 1 | $19 |
| Novo Nordisk | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$625 in reported general payments places this provider in the 60th percentile of 128 women's health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 12 | $3,540 |
| Estradiol (Twice Weekly)Estradiol | 22 | $1,504 |
| Estradiol | 38 | $555 |
| ProgesteroneProgesterone, Micronized | 16 | $268 |
| Duloxetine Hcl | 12 | $135 |
| Medroxyprogesterone Acetate | 13 | $50 |
| Clonazepam | 14 | $27 |
Paid to pharmacies, not to this prescriber.
Other women's health in Monroe
- Ann JoplingMonroe$16K
- Jennifer MillerMonroe$4K
- Christie WaltersMonroe$4K
- Mary JansMonroe$3K
- Mariana GrossMonroe$3K
- Tina SmithMonroe$1K
- Amanda HayesShreveport$51K
- Nancy WellsBossier City$47K
- Kendra Joseph-RodgersNew Orleans$10K
- Aundria CannonLafayette$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.